Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Evolocumab vs Ezetimibe in Statin-Intolerant Hypercholesterolemia (GAUSS-2)
NCT01763905Phase 3Completed
- Sponsor
- Amgen
- Start
- Jan 2013
- Primary completion
- Nov 2013
- Modality
- Monoclonal Antibodies
- Countries
- 14
01
Overview
A Phase 3 trial of evolocumab in hypercholesterolemia, sponsored by Amgen. Started Jan 2013; status: completed.
02
Drugs
evolocumab
03
Conditions
hypercholesterolemia
Beyond the preview
Go deeper on NCT01763905.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01763905.